Skip to main content
Premium Trial:

Request an Annual Quote

Biocartis Awarded $2.3M Grant to Build Out MDx Platform

NEW YORK (GenomeWeb) – The Flemish Government has awarded Biocartis a €1.7 million ($2.3 million) grant to build out the capabilities of the company's Idylla molecular diagnostics platform, Biocartis said today.

Biocartis said it will use the funding to further develop its hybrid multiplexing technology to detect and quantify multiple biomarker types on single Idylla tests. The company has developed oncology assays that can already detect tens of biomarkers of the same type.

"The hybrid multiplexing project will strengthen our competitive position in the oncology field and open new opportunities in other disease, such as infectious and genetic diseases," Biocartis CSO Geert Maertens said in a statement.

Earlier this month Biocartis and Abbott announced a collaboration to develop and commercialize companion diagnostic tests for use on the Idylla platform.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.